Dr. Martens PLC

Declaration of Voting Results & Voting Rights Announcements • Jul 14, 2022

National Storage Mechanism | Additional information

RNS Number : 5154S

Dr. Martens PLC

14 July 2022

14 July 2022

DR. MARTENS PLC

RESULT OF ANNUAL GENERAL MEETING

14 JULY 2022

The Company announces the results of voting at its Annual General Meeting held earlier today and confirms that all resolutions were duly passed on a poll with majorities as set out below.

Resolutions 1 to 15 were proposed as Ordinary Resolutions and resolutions 16 to 19 as Special Resolutions.

Resolution		Votes For	%	Votes Against	%	Votes Total	Votes Withheld	% Voting Capital Instructed
01	Receive the 2022 Annual Report and Accounts	813,848,188	100.00	0	0.00	813,848,188	783,563	81.36%
02	Approve the Directors' Remuneration Report	807,707,382	99.15	6,923,259	0.85	814,630,641	1,110	81.44%
03	Approve the Final Dividend	811,746,252	99.65	2,885,099	0.35	814,631,351	400	81.44%
04	Re-elect Paul Mason	798,851,082	98.70	10,553,833	1.30	809,404,915	5,226,836	80.92%
05	Re-elect Kenny Wilson	809,826,477	99.41	4,804,764	0.59	814,631,241	510	81.44%
06	Re-elect Jon Mortimore	809,094,165	99.32	5,537,076	0.68	814,631,241	510	81.44%
07	Re-elect Ian Rogers	810,551,309	99.50	4,079,932	0.50	814,631,241	510	81.44%
08	Re-elect Ije Nwokorie	809,887,078	99.42	4,744,163	0.58	814,631,241	510	81.44%
09	Re-elect Lynne Weedall	791,704,376	97.19	22,926,665	2.81	814,631,041	710	81.44%
10	Re-elect Robyn Perriss	803,176,287	98.59	11,454,954	1.41	814,631,241	510	81.44%
11	Re-elect Tara Alhadeff	804,121,618	98.71	10,509,623	1.29	814,631,241	510	81.44%
12	Appoint PricewaterhouseCoopers LLP as auditor	813,775,770	99.89	855,681	0.11	814,631,451	300	81.44%
13	Authorise the Audit & Risk Committee to determine the Auditor's remuneration	814,220,813	99.95	410,638	0.05	814,631,451	300	81.44%
14	Authorise the Company and its subsidiaries to make political donations	809,153,872	99.33	5,476,763	0.67	814,630,635	1,116	81.44%
15	Authorise allotment of shares	797,319,899	97.87	17,311,344	2.13	814,631,243	508	81.44%
16	Authorise general disapplication of pre-emption rights*	813,947,595	99.92	683,756	0.08	814,631,351	400	81.44%
17	Authorise additional disapplication of pre-emption rights*	811,886,184	99.66	2,745,167	0.34	814,631,351	400	81.44%
18	Authorise purchase of own shares*	813,899,052	99.95	446,465	0.05	814,345,517	286,234	81.41%
19	Authorise calling of general meetings on 14 days' notice*	795,268,484	97.62	19,362,867	2.38	814,631,351	400	81.44%

*Special Resolution

The votes of independent shareholders on the resolutions concerning the election or re-election of the Independent Non-Executive Directors are set out below:

Resolution		Votes For	%	Votes Against	%	Votes Total	Votes Withheld	% Independent Capital Instructed
07	Re-elect Ian Rogers	440,608,869	99.08	4,079,932	0.92	444,688,801	510	70.55%
08	Re-elect Ije Nwokorie	439,944,638	98.93	4,744,163	1.07	444,688,801	510	70.55%
09	Re-elect Lynne Weedall	421,761,936	94.84	22,926,665	5.16	444,688,601	710	70.55%
10	Re-elect Robyn Perriss	433,233,847	97.42	11,454,954	2.58	444,688,801	510	70.55%

Notes:

1. Votes "For" and "Against" are expressed as a percentage of votes received.

2. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

3. As at 6.30pm on 12 July 2022 the Company had a total of 1,000,283,652 ordinary shares with voting rights in issue. The total independent voting capital, used to calculate the votes of independent shareholders on resolutions 7-10, was 630,341,212.

4. In accordance with Listing Rule 9.6.2R, copies of the resolutions passed as special business will shortly be available for inspection on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.  

Enquiries

Investors and analysts                         

Mark Blythman, Interim Director of Investor Relations                   +44 7570 871207

mark.blythman@drmartens.com

Media                                                     

Gill Hammond, Director of Communications                          +44 7384 214248

Maitland                                                    +44 20 7379 5151

Clinton Manning                                       +44 7711 972 662

Joanna Davidson                                      +44 7827 254 567

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. 

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGGPUPWMUPPGGC